Clinical Trials for Marginal Zone Lymphoma (MZL)

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

NCT ID: NCT07121946

This clinical trial is testing a new drug called LTZ-301 to see if it is safe and well-tolerated in adults with certain types of non-Hodgkin lymphoma (a kind of blood cancer) that has come back or ...

A Trial to Learn if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

NCT ID: NCT06149286

This clinical trial is studying a new treatment for adults with two specific types of cancer: follicular lymphoma and marginal zone lymphoma, especially for those whose cancer has returned after tr...

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

NCT ID: NCT05131022

This clinical trial is studying a new medication called NX-5948 to see how safe it is and how well it can help adults with certain types of advanced B-cell cancers, such as Chronic Lymphocytic Leuk...

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

NCT ID: NCT04830137

This clinical trial is investigating a new treatment called NX-2127 for adults with certain types of advanced B-cell cancers, such as Chronic Lymphocytic Leukemia (CLL) and various types of lymphom...

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T

NCT ID: NCT04488354

Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms

NCT ID: NCT06043011

The RUBIN trial is focused on collecting important information about various blood cancers, including Chronic Lymphocytic Leukemia (CLL) and several types of lymphoma. The goal is to create a natio...

REal World Data in LYmphoma and Survival in Adults

NCT ID: NCT03869619

The REal World Data in LYmphoma and Survival in Adults trial, also known as the REALYSA cohort, is studying how different types of lymphoma affect patients over time. This trial aims to gather impo...